| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1983PNAS...80.6264A |
| P356 | DOI | 10.1073/PNAS.80.20.6264 |
| P932 | PMC publication ID | 394276 |
| P698 | PubMed publication ID | 6604914 |
| P5875 | ResearchGate publication ID | 16591233 |
| P2093 | author name string | Smith JM | |
| Roberts AB | |||
| Sporn MB | |||
| De Larco JE | |||
| Anzano MA | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization | Q28270658 | ||
| Serum contains a platelet-derived transforming growth factor | Q36310452 | ||
| Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. | Q36320239 | ||
| New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues | Q36366470 | ||
| Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction | Q36394057 | ||
| Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors | Q36405679 | ||
| Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor | Q37349044 | ||
| Growth factors from murine sarcoma virus-transformed cells | Q37593227 | ||
| Purification and initial characterization of a type beta transforming growth factor from human placenta | Q37614986 | ||
| THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY | Q39512876 | ||
| Growth factors produced by sarcoma virus-transformed cells | Q40177481 | ||
| Anchorage-independent growth-conferring factor production by rat mammary tumor cells | Q42824543 | ||
| Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells | Q42824660 | ||
| Mouse embryonic transforming growth factors related to those isolated from tumor cells | Q42825867 | ||
| Properties of a sarcoma-growth-factor-like peptide from cells transformed by a temperature-sensitive sarcoma virus | Q42826451 | ||
| Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors | Q42828881 | ||
| Transformation Induced by Abelson Murine Leukemia Virus Involves Production of a Polypeptide Growth Factor | Q43634964 | ||
| Identification of an epidermal growth factor-related transforming growth factor from rat fetuses | Q44185976 | ||
| Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization | Q44266849 | ||
| Cells transformed by rous sarcoma virus release transforming growth factors | Q45799264 | ||
| Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors | Q45803047 | ||
| Transforming growth factor production by chemically transformed cells | Q52826927 | ||
| Transforming growth factors from neoplastic and nonneoplastic tissues | Q53559329 | ||
| Purification by reverse-phase high-performance liquid chromatography of an epidermal growth factor-dependent transforming growth factor | Q72118581 | ||
| 2 High-performance liquid chromatography and picomole-level detection of peptides and proteins | Q72657649 | ||
| Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture | Q72926745 | ||
| Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans | Q72952350 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 6264-6268 | |
| P577 | publication date | 1983-10-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors | |
| P478 | volume | 80 |
| Q41366482 | 8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer |
| Q42797971 | A sensitive screening assay for secreted motility-stimulating factors |
| Q33248661 | Abnormal expression of Col X, PTHrP, TGF-beta, bFGF, and VEGF in cartilage with Kashin-Beck disease |
| Q34593947 | Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene |
| Q37374782 | Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line |
| Q70231655 | Behavior of transforming growth factors in serum-free media: an improved assay for transforming growth factors |
| Q37106890 | Cell motility, a principal requirement for metastasis |
| Q36214857 | Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alpha |
| Q73880893 | Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding |
| Q42847452 | Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor |
| Q55494181 | Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis. |
| Q44110661 | Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo |
| Q41445914 | Constitutive over-expression of transforming growth factor-alpha in rat liver epithelial cells leads to increased cell cycling without transformation |
| Q36304149 | Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade |
| Q36874189 | Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells |
| Q36811215 | Development of a retroviral vector for inducible expression of transforming growth factor beta 1. |
| Q40170614 | Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair. |
| Q36237924 | Different roles of TGF-β in the multi-lineage differentiation of stem cells. |
| Q52265829 | Early mouse embryos produce and release factors with transforming growth factor activity. |
| Q41341338 | Effect of TGF-beta on differentiated organoids of the colon carcinoma cell line LIM 1863. |
| Q72709006 | Effect of transforming growth factor-alpha on gastric acid secretion in rats and monkeys |
| Q67234238 | Effect of transforming growth factor-beta on DNA synthesis by growth plate chondrocytes: modulation by factors present in serum |
| Q73473130 | Effects of epidermal growth factor on collagen expression by rat kidney mesangial cells in culture |
| Q36216679 | Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta |
| Q42128333 | Epidermal and transforming growth factor alpha in patients with breast tumours |
| Q36745372 | Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes |
| Q43242639 | Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications |
| Q90886378 | Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics |
| Q42818380 | Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins |
| Q34541763 | Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel. |
| Q42087783 | Expression of transforming growth factor-alpha in primary human colon and lung carcinomas |
| Q35607475 | Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions |
| Q54127845 | Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. |
| Q42490400 | Fibronectin inhibits the terminal differentiation of human keratinocytes |
| Q42445212 | Flat revertants derived from kirsten murine sarcoma virus-transformed cells produce transforming growth factors |
| Q68205515 | Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: identification of transforming growth factor-beta as a suppressive factor |
| Q72399491 | Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor |
| Q36214427 | Growth control in cultured 3T3 fibroblasts. V. Purification of an Mr 13,000 polypeptide responsible for growth inhibitory activity |
| Q33560803 | Growth regulation of skin cells by epidermal cell-derived factors: implications for wound healing |
| Q59790432 | HMGB1/autophagy pathway mediates the atrophic effect of TGF-β1 in denervated skeletal muscle |
| Q77495216 | High levels of transforming growth factor-alpha (TGF-alpha) mRNA may predict local relapses in early stage urinary bladder cancer |
| Q40649367 | High-level expression of c-H-ras1 fails to fully transform rat-1 cells |
| Q52273529 | Immortalized B lymphocytes produce B-cell growth factor. |
| Q53401310 | Immunopathological features of human pulmonary tumors following low-dose interleukin-2. |
| Q36885110 | Increased secretion of type beta transforming growth factor accompanies viral transformation of cells |
| Q36796387 | Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts |
| Q34337298 | Inhibitory action of transforming growth factor beta on endothelial cells |
| Q73067831 | Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophage-lineage hemopoietic progenitor cells |
| Q28564238 | Involvement of transforming growth factor alpha in the regulation of rat ovarian X-linked inhibitor of apoptosis protein expression and follicular growth by follicle-stimulating hormone |
| Q35861493 | Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation |
| Q42132569 | Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines |
| Q40667295 | Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor |
| Q40089245 | Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death |
| Q36346393 | Mathematical model of TGF-βsignalling: feedback coupling is consistent with signal switching. |
| Q38505577 | Melatonin modulation of estrogen‐regulated proteins, growth factors, and proto‐oncogenes in human breast cancer |
| Q52040083 | Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process. |
| Q34610078 | Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones |
| Q37938041 | Molecules, cancer, and the surgeon. A review of molecular biology and its implications for surgical oncology |
| Q38864929 | Nerve growth factor exposure promotes tubular epithelial-mesenchymal transition via TGF-β1 signaling activation |
| Q57181977 | Noncoding RNA Ginir functions as an oncogene by associating with centrosomal proteins |
| Q33735927 | Notch signaling activation suppresses v-Src-induced transformation of neural cells by restoring TGF-β-mediated differentiation |
| Q39138333 | Oncogenes and transmembrane cell signaling |
| Q39264234 | Pearl extract enhances the migratory ability of fibroblasts in a wound healing model |
| Q41745683 | Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines |
| Q37405342 | Potentiation of growth factor activity by exogenous c-myc expression. |
| Q42139294 | Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation |
| Q36351780 | Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth |
| Q35818837 | Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth |
| Q74603006 | Purification and characterization of TEF1, a transcription factor that controls the human transforming growth factor-alpha promoter |
| Q41225764 | Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha |
| Q33839963 | Sequence-specific 1H-NMR assignments and identification of two small antiparallel beta-sheets in the solution structure of recombinant human transforming growth factor alpha |
| Q37672941 | Serum independence of transcription from the promoter of an avian retrovirus in v-src-transformed cells is a primary, intracellular effect of increased tyrosine phosphorylation |
| Q72853742 | Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay |
| Q71089126 | Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis |
| Q33674328 | Smad signaling in skeletal development and regeneration |
| Q41861658 | Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus |
| Q37575727 | Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets |
| Q37679043 | Stimulation of glucose uptake by transforming growth factor beta: evidence for the requirement of epidermal growth factor-receptor activation |
| Q42793438 | Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis |
| Q40645600 | Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bonds |
| Q54392042 | TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity. |
| Q53534770 | TGF-beta: 20 years and counting. |
| Q35826016 | TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth |
| Q41505601 | TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion |
| Q24312466 | The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis |
| Q37859415 | The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring |
| Q24532213 | The latent transforming growth factor beta binding protein (LTBP) family |
| Q35909651 | The physiology of transforming growth factor-alpha |
| Q41670362 | The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors |
| Q37943202 | The transforming growth factor-betas: past, present, and future |
| Q36352081 | Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia |
| Q45345483 | Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene |
| Q40678426 | Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src |
| Q39511011 | Transforming genes and target cells of murine spleen focus-forming viruses |
| Q31160943 | Transforming growth factor alpha in epithelial proliferative diseases of the breast |
| Q35608343 | Transforming growth factor alpha inhibits secretion of gastric acid |
| Q36767000 | Transforming growth factor alpha: an aromatic side chain at position 38 is essential for biological activity |
| Q36785343 | Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities |
| Q42467495 | Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma |
| Q41650318 | Transforming growth factor beta stimulates mitogenically mouse NIH3T3 fibroblasts and those cells transformed by the EJ-H ras oncogene |
| Q35610349 | Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro |
| Q38132176 | Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer |
| Q35194627 | Transforming growth factor-alpha: characterization of the BamHI, RsaI, and TaqI polymorphic regions |
| Q34568780 | Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts |
| Q35632615 | Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis |
| Q36401260 | Transforming growth factor-beta is a potent negative regulator of human lymphocytes |
| Q36213296 | Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha |
| Q41196594 | Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. |
| Q37365281 | Transforming growth factor-beta--mullerian inhibiting substance family of growth regulators |
| Q36465897 | Transforming growth factor-beta: possible roles in carcinogenesis |
| Q47744629 | Transforming growth factor-ßs as modulators of pericellular proteolytic events |
| Q47744635 | Transforming growth factor-β receptors |
| Q39573228 | Transforming growth factors in the regulation of malignant cell growth and invasion |
| Q34165482 | Tumor cell autocrine motility factor |
| Q39736054 | Tumor cell metastasis |
| Q35599307 | Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells |
| Q37672515 | Type beta transforming growth factor: a bifunctional regulator of cellular growth |
| Q93575827 | Use of a urea and guanidine-HCl-propanol solvent system to purify a growth inhibitory glycopeptide by high-performance liquid chromatography |
| Q33951992 | What role(s) for TGFalpha in the central nervous system? |
| Q39185442 | miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines |
| Q40667031 | v-src inhibits differentiation via an extracellular intermediate(s). |
Search more.